Shopping Cart 0
Cart Subtotal
AED 0

Living Cell Technologies Ltd (LCT) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Living Cell Technologies Ltd (LCT)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT develops its candidates based on its proprietary encapsulation technology, Immupel. Its lead product candidate, NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. It is in Phase IIb clinical trials for the treatment of Parkinson's disease. The company is also developing the candidate in a number of other central nervous system indications, including Huntington's, Alzheimer's and motor neurone diseases including amyotrophic lateral sclerosis (ALS). LCT's joint venture, Diatranz Otsuka Limited develops Diabecell, a cell therapy for type 1 diabetes. LCT is headquartered in Auckland, the New Zealand.

Living Cell Technologies Ltd Key Recent Developments

Aug 31,2018: Living Cell Technologies: Roy Austin has stepped down from his role as Chairman and from his post

Jul 26,2018: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2018

Apr 11,2018: LCT Strategy Update

Oct 18,2017: Living Cell Technologies: Quarterly Cash Flow Report 30 September 2017

Aug 23,2017: Living Cell Technologies: Preliminary Final Report 30 June 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Living Cell Technologies Ltd-Key Facts 5

Living Cell Technologies Ltd-Key Employees 6

Living Cell Technologies Ltd-Key Employee Biographies 7

Living Cell Technologies Ltd-Major Products and Services 8

Living Cell Technologies Ltd-History 9

Living Cell Technologies Ltd-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Joint Venture 12

Section 2-Company Analysis 13

Company Overview 13

Living Cell Technologies Ltd-Business Description 14

Living Cell Technologies Ltd-Corporate Strategy 15

Living Cell Technologies Ltd-SWOT Analysis 16

SWOT Analysis-Overview 16

Living Cell Technologies Ltd-Strengths 16

Living Cell Technologies Ltd-Weaknesses 17

Living Cell Technologies Ltd-Opportunities 18

Living Cell Technologies Ltd-Threats 19

Living Cell Technologies Ltd-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Living Cell Technologies Ltd, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

Aug 31, 2018: Living Cell Technologies: Roy Austin has stepped down from his role as Chairman and from his post 29

Jul 26, 2018: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2018 30

Apr 11, 2018: LCT Strategy Update 31

Oct 18, 2017: Living Cell Technologies: Quarterly Cash Flow Report 30 September 2017 33

Aug 23, 2017: Living Cell Technologies: Preliminary Final Report 30 June 2017 34

Jul 20, 2017: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2017 35

Feb 22, 2017: Living Cell Technologies H1 loss up 36

Section 6-Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41


List Of Figure

List of Figures

Living Cell Technologies Ltd, Performance Chart (2014-2018) 23

Living Cell Technologies Ltd, Ratio Charts 25

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27


List Of Table

List of Tables

Living Cell Technologies Ltd, Key Facts 5

Living Cell Technologies Ltd, Key Employees 6

Living Cell Technologies Ltd, Key Employee Biographies 7

Living Cell Technologies Ltd, Major Products and Services 8

Living Cell Technologies Ltd, History 9

Living Cell Technologies Ltd, Subsidiaries 11

Living Cell Technologies Ltd, Joint Venture 12

Living Cell Technologies Ltd, Key Competitors 20

Living Cell Technologies Ltd, Annual Ratios 21

Living Cell Technologies Ltd, Annual Ratios (Cont...1) 22

Living Cell Technologies Ltd, Interim Ratios 24

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Living Cell Technologies Ltd, Recent Deals Summary 28

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Living Cell Technologies Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Medivation Inc

Neurosciences Victoria Ltd

Avita Medical Ltd

Mesoblast Ltd

biosensis Pty Ltd

Karo Bio Discovery AB

Living Cell Technologies Ltd (LCT)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Living Cell Technologies Ltd (LCT) is a biotechnology company that develops cell-based therapeutics for the treatment of neurological diseases, diabetes, and stroke and hearing loss. It focuses on discovering regenerative treatments which restore function using naturally occurring cells. LCT develops its candidates based on its proprietary encapsulation technology, Immupel. Its lead product candidate, NTCELL is an alginate coated capsule containing clusters of neonatal porcine choroid plexus cells. It is in Phase IIb clinical trials for the treatment of Parkinson's disease. The company is also developing the candidate in a number of other central nervous system indications, including Huntington's, Alzheimer's and motor neurone diseases including amyotrophic lateral sclerosis (ALS). LCT's joint venture, Diatranz Otsuka Limited develops Diabecell, a cell therapy for type 1 diabetes. LCT is headquartered in Auckland, the New Zealand.

Living Cell Technologies Ltd Key Recent Developments

Aug 31,2018: Living Cell Technologies: Roy Austin has stepped down from his role as Chairman and from his post

Jul 26,2018: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2018

Apr 11,2018: LCT Strategy Update

Oct 18,2017: Living Cell Technologies: Quarterly Cash Flow Report 30 September 2017

Aug 23,2017: Living Cell Technologies: Preliminary Final Report 30 June 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Living Cell Technologies Ltd-Key Facts 5

Living Cell Technologies Ltd-Key Employees 6

Living Cell Technologies Ltd-Key Employee Biographies 7

Living Cell Technologies Ltd-Major Products and Services 8

Living Cell Technologies Ltd-History 9

Living Cell Technologies Ltd-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Joint Venture 12

Section 2-Company Analysis 13

Company Overview 13

Living Cell Technologies Ltd-Business Description 14

Living Cell Technologies Ltd-Corporate Strategy 15

Living Cell Technologies Ltd-SWOT Analysis 16

SWOT Analysis-Overview 16

Living Cell Technologies Ltd-Strengths 16

Living Cell Technologies Ltd-Weaknesses 17

Living Cell Technologies Ltd-Opportunities 18

Living Cell Technologies Ltd-Threats 19

Living Cell Technologies Ltd-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Living Cell Technologies Ltd, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

Aug 31, 2018: Living Cell Technologies: Roy Austin has stepped down from his role as Chairman and from his post 29

Jul 26, 2018: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2018 30

Apr 11, 2018: LCT Strategy Update 31

Oct 18, 2017: Living Cell Technologies: Quarterly Cash Flow Report 30 September 2017 33

Aug 23, 2017: Living Cell Technologies: Preliminary Final Report 30 June 2017 34

Jul 20, 2017: Living Cell Technologies: Appendix 4C Quarterly Cash Flow Report 30 June 2017 35

Feb 22, 2017: Living Cell Technologies H1 loss up 36

Section 6-Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41


List Of Figure

List of Figures

Living Cell Technologies Ltd, Performance Chart (2014-2018) 23

Living Cell Technologies Ltd, Ratio Charts 25

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 27


List Of Table

List of Tables

Living Cell Technologies Ltd, Key Facts 5

Living Cell Technologies Ltd, Key Employees 6

Living Cell Technologies Ltd, Key Employee Biographies 7

Living Cell Technologies Ltd, Major Products and Services 8

Living Cell Technologies Ltd, History 9

Living Cell Technologies Ltd, Subsidiaries 11

Living Cell Technologies Ltd, Joint Venture 12

Living Cell Technologies Ltd, Key Competitors 20

Living Cell Technologies Ltd, Annual Ratios 21

Living Cell Technologies Ltd, Annual Ratios (Cont...1) 22

Living Cell Technologies Ltd, Interim Ratios 24

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 26

Living Cell Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 27

Living Cell Technologies Ltd, Recent Deals Summary 28

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Living Cell Technologies Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Medivation Inc

Neurosciences Victoria Ltd

Avita Medical Ltd

Mesoblast Ltd

biosensis Pty Ltd

Karo Bio Discovery AB

chat_bubbleLet's Chat